[1]马飞艳,王　娟,樊　萍.川崎病患儿血清趋化素和缺血修饰清蛋白水平与冠状动脉损伤的相关性及在治疗中的应用价值[J].现代检验医学杂志,2021,36(03):72-75.[doi:10.3969/j.issn.1671-7414.2021.03.016]
　MA Fei-yan,WANG Juan,FAN Ping.Relationship between the Levels of Chemokine and Ischemia-modified Albuminin Serum and Coronary Artery Injury in Children with Kawasaki Disease and the Application Value in the Treatment[J].Journal of Modern Laboratory Medicine,2021,36(03):72-75.[doi:10.3969/j.issn.1671-7414.2021.03.016]
点击复制

川崎病患儿血清趋化素和缺血修饰清蛋白水平与冠状动脉损伤的相关性及在治疗中的应用价值()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第36卷
期数:
2021年03期
页码:
72-75
栏目:
论　著
出版日期:
2021-05-31

文章信息/Info

Title:
Relationship between the Levels of Chemokine and Ischemia-modified Albuminin Serum and Coronary Artery Injury in Children with Kawasaki Disease and the Application Value in the Treatment
文章编号:
1671-7414（2021）03-072-04
作者:
马飞艳; 王　娟; 樊　萍
(1. 咸阳市妇幼保健院检验科 , 陕西咸阳 712000；2. 陕西省森工医院检验科 , 西安 710300；3. 咸阳市第一人民医院检验科 , 陕西咸阳 712000)
Author(s):
MA Fei-yan1;  WANG Juan2;  FAN Ping3
（1.Department of Clinical Laboratory,the Maternal and Child Health Hospital of Xianyang, Shaanxi Xianyang712000, China ；2.Department of Clinical Laboratory, the Forest Industry Hospital of Shaanxi, Xi’an 710300，China ；3.Department of Clinical Laboratory,the First People’s Hospital of Xianyang, Shaanxi Xianyang 712000, China）
关键词:
川崎病; 冠状动脉损伤; 趋化素; 缺血修饰清蛋白
分类号:
R551.2；R392.11
DOI:
10.3969/j.issn.1671-7414.2021.03.016
文献标志码:
A
摘要:
目的　探讨血清趋化素 (Chemerin) 和缺血修饰清蛋白 (Ischemia-modified albumin,IMA) 水平与川崎病 (Kawasakidisease,KD) 患儿冠状动脉损伤的相关性及在治疗中的应用。方法　选取 2014 年 8 月 ~2019 年 8 月在咸阳市第一人民医院、陕西省森工医院和咸阳市妇幼保健院就诊的 75 例 KD 患儿作为研究对象。依据患儿超声心动图结果分为冠状动脉正常组 (normal coronary artery,NCA)48 例组和冠状动脉病变组 (Coronary artery disease,CAD)27 例，选取 32 例同期体检健康者作为对照组。KD 患儿血清 Chemerin 水平检测采用酶联免疫吸附试验法。IMA 水平检测采用清蛋白 - 钴结合法。通过彩色多普勒超声检查分析 KD 患儿的冠状动脉左主干 (left main coronary artery,LMCA) 内径，左前降支 (left anteriordescending coronary artery,LADC) 内径及右冠状动脉近端 (proximal right coronary artery,PRCA) 内径。比较分析以上指标的变化与 KD 患儿冠状动脉损伤的相关性。结果　对照组和 NCA 组患儿治疗后和治疗前 ,CAD 组患儿治疗后和治疗前的血清 Chemerin 和 IMA 水平分别为 203.32±26.37，247.50±36.42, 317.50±52.16，279.21±45.63，356.89±59.28ng/ml 和 41.20±11.37，55.39±17.45，76.36±26.18，69.50±22.23，92.67±33.49U/ml。NCA 组和 CAD 组患儿治疗前的Chemerin 和 IMA 水平与对照组比较明显增高 , 其中 CAD 组增高更显著。NCA 组和 CAD 组患儿治疗后的 Chemerin 和IMA 水平与对照组比较明显增高 , 其中 CAD 组增高更显著，差异均有统计学意义 (F=31.50~36.10, 均 P=0.000)。CAD组患儿治疗前的血清Chemerin和IMA水平分别与LMCA内径、LADC内径和PRCA内径呈正相关性（rChemerin=0.693, 0.652,0.637, 均 P<0.01;rIMA=0.669, 0.620, 0.619, 均 P<0.01）。结论 IMA 和 Chemerin 可能与 KD 的发生发展密切相关。检测IMA 和 Chemerin 水平可以为 KD 的诊治及冠状动脉损伤的评估提供依据。

参考文献/References:

[1] 苟永英 , 李刚 , 刘东 , 等 . 丙种球蛋白敏感型川崎病和耐药型川崎病冠状动脉病变对比研究 [J]. 成都医学院学报 ,2019,14(6):791-794,799. GOU Yongying, LI Gang, LIU Dong. Comparativestudy of coronary artery lesions in intravenous immunoglobiclin sensitive Kawasaki disease and insensitiveKawasaki disease[J]. Journal of Chengdu Medical College, 2019,14 (6): 791-794,799.
[2] 相虹 , 常明 , 王秋霞 , 等 . 川崎病患儿治疗前后血清脂源性细胞因子的变化及意义 [J]. 中国当代儿科杂志 ,2020,22(1):53-56. XIANG Hong, CHANG Ming, WANG Qiuxia, et al.Changes in serum levels of adipokine after treatment inchildren with Kawasaki disease[J]. Chinese Journal ofContemporary Pediatrics, 2020,22 (1): 53-56.
[3] 陈棉 , 方声 , 王敏娜 , 等 . 血清 IMA,Lp-PLA2 对川崎病患儿冠状动脉损伤的诊断价值 [J]. 中国妇幼保健 ,2019,34(21):4948-4951. CHEN Mian, FANG Sheng, WANG Minna, et al. Diagnostic value of serum IMA and Lp-PLA2 for coronaryartery injury in children with Kawasaki disease [J].Maternal and Child Health Care of China, 2019,34 (21):4948-4951.
[4] 张 颖 , 犹登霞 , 周杰林 . 典型川崎病与不完全川崎病的临床特征分析 [J]. 中国妇幼健康研究 , 2018,29(11):1475-1479. ZHANG Ying,YU Dengxia, ZHOU Jielin. Clinicalcharacteristics of typical Kawasaki disease andincomplete Kawasaki disease [J]. Chinese Journal ofwomen and Child Health Research, 2018,29 (11): 1475-1479.
[5] 郑晶晶 , 夏焙 , 陈伟玲 , 等 . 超声心动图定量评价川崎病患儿 7 ～ 14 年冠状动脉 Z 值变化 [J]. 中国医学影像技术 ,2018,34(4): 538-542. ZHENG Jingjing, XIA Bei, CHEN Weiling, et al.Echocardiographic assessment of coronary arteryZ scores in children with Kawasaki disease after7~14 years[J].Chinese Journal of Medical ImagingTechnology, 2018,34(4): 538-542.
[7] 张少锋 , 殷利平 . 川崎病患儿血清 chemerin,omentin1,APN,IL-1β,TNF-α 水平检测及其意义 [J]. 临床急诊杂志 ,2019,20(1):65-69. ZHANG Shaofeng, YIN Liping.The detection andsignificance of serum chemorin, omestin-1, APN, IL1beta and TNF-alpha in children with Kawasaki disease[J]. Journal of Clinical Emergency Call, 2019,20 (1):65-69.
[8] 陈慎 , 杜明君 , 宋雅琴 . 宫颈组织 HPV DNA 与血清Chemerin,Leptin 水平联合检测对宫颈癌早期诊断的价值分析 [J]. 现代检验医学杂志 ,2019,34(3):42-46. CHEN Shen, DU Mingjun, SONG Yaqin. Value ofcombined detection of HPV DNA and serum levelsof Chemorin and Leptin in early diagnosis of cervicalcancer [J]. Journal of Modern Laboratory Medicine,2019,34 (3): 42-46.
[9] 刘艳宾 , 杨树涵 , 陈红伟 , 等 . 老年冠心病患者脂肪细胞因子与冠状动脉病变严重程度的相关性 [J]. 实用医学杂志 , 2019,35(11):1799-1804. LIU Yanbin, YANG Shuhan, CHEN Hongwei, etal. Association between adipocytokines levels andcoronary artery lesions in elderly patients with coronaryheart disease [J]. The Journal of Practical Medicine,2019,35 (11): 1799-1804.
[10] 王颂杨 , 吴 斌 , 徐伟健 , 等 . 血 清 IMA, MCP-1,CD163 表达水平与急性冠脉综合征患者病情严重程度的关系研究 [J]. 标 记免疫分析与临床 , 2019,26(2):299-302,308. WANG Songyang, WU Bin, XU Weijian, et al.Relationship between the serum levels of IMA, MCP-1and CD163 and severity of acute coronary syndrome [J].Labeled Immunoassay and Clinical Medicine, 2019,26(2): 299-302,308.
[11] 周立宾 , 薛红 . ACS 患者血清 IMA, Hcy, NT-proBNP 水平变化及其诊断价值[J].医学临床研究,2019,36(1):175-176,181. ZHOU Libin, XUE Hong. Changes of serum levelsof IMA, Hcy, NT proBNP in patients with ACS andtheir diagnostic value [J]. Journal of Clinical Research,2019,36 (1): 175-176,181.

相似文献/References:

[1]盛伟武,高春彪,管华玲.miRNA-145和miRNA-143在川崎病患儿血浆中的表达及意义[J].现代检验医学杂志,2016,31(05):34.[doi:10.3969/j.issn.1671-7414.2016.05.009]
　SHENG Wei-wu,GAO Chun-biao,GUAN Hua-ling.Expression and Its Significance of MicroRNA-145 and MicroRNA-143 in Plasma in Children with Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2016,31(03):34.[doi:10.3969/j.issn.1671-7414.2016.05.009]
[2]靳剑芸,李启亮,宋文琪.血浆血栓弹力图与抗凝血酶Ⅲ检测对儿童川崎病诊断的应用价值[J].现代检验医学杂志,2017,32(05):130.[doi:10.3969/j.issn.1671-7414.2017.05.017]
　JIN Jian-yun,LI Qi-liang,SONG Wen-qi.Correlation Discussion of Blood Plasma Thromboelastography Values and Antithrombin III Level in Children's Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2017,32(03):130.[doi:10.3969/j.issn.1671-7414.2017.05.017]
[3]刘丽莎,李喆倩,谈 诚,等.川崎病并发冠脉损伤患儿血清活化HUVECs NF-κB促使MMP-9 mRNA水平上调的实验研究[J].现代检验医学杂志,2018,33(01):131.[doi:10.3969/j.issn.1671-7414.2018.01.001]
　LIU Li-sha,LI Zhe-qian,TAN Cheng,et al.Experimental Study on the Up-Regulation of NF- kappa B and MMP-9 mRNA Level in HUVECs Stimulated by Serum from Children with Coronary Artery Lesions of Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2018,33(03):131.[doi:10.3969/j.issn.1671-7414.2018.01.001]
[4]李俏,张李钰,赵传梅,等.西安地区儿童免疫球蛋白无反应型川崎病危险因素分析及预测评分体系的建立[J].现代检验医学杂志,2019,34(01):5.[doi:10.3969/j.issn.1671-7414.2019.01.002]
　LI Qiao,ZHANG Li-yu,ZHAO Chuan-mei,et al.Analysis of Risk Factors of Intravenous Immunoglobulin in Children with Non-Responsive Kawasaki Disease in Xi’an Area and Establishment of Its Predictive Scoring System[J].Journal of Modern Laboratory Medicine,2019,34(03):5.[doi:10.3969/j.issn.1671-7414.2019.01.002]
[5]黄君华,崔自明,张书婉,等.完全性川崎病患儿血清 25-羟基维生素 D水平检测对预测 IVIG抵抗的价值研究[J].现代检验医学杂志,2022,37(01):28.[doi:10.3969/j.issn.1671-7414.2022.01.006]
　HUANG Jun-hua,CUI Zi-ming,ZHANG Shu-wan,et al.Value of Serum 25-Hydroxyvitamin D Levels in the Prediction of Intravenous Immunoglobulin Resistance in Patients withComplete Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2022,37(03):28.[doi:10.3969/j.issn.1671-7414.2022.01.006]
[6]张俊民,许爱平,赵利平,等.川崎病患儿血清酸性鞘磷脂酶、钙调神经磷酸酶水平和炎症因子表达的相关性以及与免疫球蛋白治疗效果的关系研究[J].现代检验医学杂志,2022,37(05):180.[doi:10.3969/j.issn.1671-7414.2022.05.036]
　ZHANG Jun-min,XU Ai-ping,ZHAO Li-ping,et al.Correlation between Serum Acid Sphingomyelinase, Calcineurin Levels and Expression of Inflammatory Factors in Children with Kawasaki Disease and the Relationship with the Therapeutic Effect of Immunoglobulin[J].Journal of Modern Laboratory Medicine,2022,37(03):180.[doi:10.3969/j.issn.1671-7414.2022.05.036]
[7]张书婉,黄君华,吴文婧,等.外周血 NLR 与 PLR 对儿童完全型川崎病冠状动脉损伤的预测分析[J].现代检验医学杂志,2020,35(06):38.[doi:doi:10.3969/j.issn.1671-7414.2020.06.010]
　ZHANG Shu-wan,HUANG Jun-hua,WU Wen-jing,et al.Prediction Analysis of NLR and PLR for the Development of Coronary ArteryLesions in Patients with Complete Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2020,35(03):38.[doi:doi:10.3969/j.issn.1671-7414.2020.06.010]
[8]李月悦a,唐 莉a,朱明跃b.川崎病患儿血清CTRP9 和sCD146 水平表达与冠状动脉损伤的相关性研究[J].现代检验医学杂志,2024,39(03):170.[doi:10.3969/j.issn.1671-7414.2024.03.029]
　LI Yueyuea,TANG Lia,ZHU Mingyueb.Correlation between the Expression Levels of Serum CTRP9 and sCD146 and Coronary Artery Lesions in Children with Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2024,39(03):170.[doi:10.3969/j.issn.1671-7414.2024.03.029]

备注/Memo

备注/Memo:
作者简介：马飞艳（1984-），女，大学本科，主管检验师，研究方向：心血管疾病的实验室诊断，E-mail：407530263@qq.com。
通讯作者：王娟（1987-)，女，大学本科，主管检验师，研究方向：心血管疾病的实验室诊断，E-mail：1781292176@qq.com。
更新日期/Last Update: 1900-01-01